Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan L Curry

Showing results (131-140 of 194) with videos related to

Pageof 20
Sort By:
Frontiers in Oncology|March 22, 2021
Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity ReactionPaul V Viscuse, Mario L Marques-Piubelli, Meghan M Heberton, et al.
Haematologica|January 27, 2022
Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significanceKevin E Fisher, Lizmery S Ferguson, Amy M Coffey, et al.
Journal of Cutaneous Pathology|March 9, 2022
Eosinophilic homogeneous intracytoplasmic inclusion bodies: Unique viral cytopathic changes associated with epidermodysplasia verruciformis and human papillomavirus type 49Brooke R Bartley, Auris Huen, Peter L Rady, et al.
Journal of Cutaneous Pathology|August 18, 2016
Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel findingRami N Al-Rohil, Carlos A Torres-Cabala, Anisha Patel, et al.
The American Journal of Dermatopathology|April 21, 2020
BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like MelanomaPei-Ling Chen, Nastaran Neishaboori, Michael T Tetzlaff, et al.
Journal of Cutaneous Pathology|June 23, 2022
Amyloid deposition with a granulomatous reaction in a resection specimen: A clue for a pre-existing Merkel cell carcinomaAimi T Rothrock, Luan D Truong, Ahmed Shehabeldin, et al.
Archives of Pathology & Laboratory Medicine|December 8, 2020
Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous MelanomaHaider A Mejbel, Carlos A Torres-Cabala, Denái R Milton, et al.
Journal of Cutaneous Pathology|January 6, 2025
Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic GenesErol Can Bayraktar, Phyu P Aung, Pavandeep Gill, et al.
Journal of Cutaneous Pathology|April 11, 2018
Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous patternCelestine Trinidad, Kelly C Nelson, Isabella C Glitza Oliva, et al.
Journal of Cutaneous Pathology|July 19, 2018
Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumorKrishna Arudra, Ravi Patel, Michael T Tetzlaff, et al.
Pageof 20

Showing results (131-140 of 194) with videos related to

Sort By:
Pageof 20
Frontiers in Oncology|March 22, 2021
Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity ReactionPaul V Viscuse, Mario L Marques-Piubelli, Meghan M Heberton, et al.
Haematologica|January 27, 2022
Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significanceKevin E Fisher, Lizmery S Ferguson, Amy M Coffey, et al.
Journal of Cutaneous Pathology|March 9, 2022
Eosinophilic homogeneous intracytoplasmic inclusion bodies: Unique viral cytopathic changes associated with epidermodysplasia verruciformis and human papillomavirus type 49Brooke R Bartley, Auris Huen, Peter L Rady, et al.
Journal of Cutaneous Pathology|August 18, 2016
Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel findingRami N Al-Rohil, Carlos A Torres-Cabala, Anisha Patel, et al.
The American Journal of Dermatopathology|April 21, 2020
BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like MelanomaPei-Ling Chen, Nastaran Neishaboori, Michael T Tetzlaff, et al.
Journal of Cutaneous Pathology|June 23, 2022
Amyloid deposition with a granulomatous reaction in a resection specimen: A clue for a pre-existing Merkel cell carcinomaAimi T Rothrock, Luan D Truong, Ahmed Shehabeldin, et al.
Archives of Pathology & Laboratory Medicine|December 8, 2020
Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous MelanomaHaider A Mejbel, Carlos A Torres-Cabala, Denái R Milton, et al.
Journal of Cutaneous Pathology|January 6, 2025
Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic GenesErol Can Bayraktar, Phyu P Aung, Pavandeep Gill, et al.
Journal of Cutaneous Pathology|April 11, 2018
Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous patternCelestine Trinidad, Kelly C Nelson, Isabella C Glitza Oliva, et al.
Journal of Cutaneous Pathology|July 19, 2018
Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumorKrishna Arudra, Ravi Patel, Michael T Tetzlaff, et al.
Pageof 20